Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +17.6% | +55.4% | 2 / 3 | +67.6% | -1.66 pp | -1.01 pp | +12.3% | 0.11 | 8.78 | 1.836 | +67,6% | 43,7 | +17,6% | 8.78 | 9.93 | −11,6% |
| Pts | 0 | 12 | 8 | 12 | 4 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 19.550 (close price on 2026-10-19)EPS (TTM): 2.227
Financial charts
1.Revenue & growth
VND bn1.836Q2/26
1.Revenue & growth
VND bn1.836Q2/26
2.Profit & growth
VND bn43,7Q2/26
3.Profit mix (Penman)
VND bn97,5Q2/26
4.Margins & cost structure
%7.8%Q2/26
5.Returns & cash cycle
% · days20.5%Q2/26
6.Earnings quality & cash
VND bn20,7Q2/26
7.Asset structure
VND bn2.052Q2/26
8.Funding & debt health
VND bn · times2.052Q2/26
9.Revenue backlog
VND bn1,78Q2/26
10.Valuation
times · %8,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.245Q2/26
Adjusted EPS growth, latest quarter
17.6%
Average adjusted EPS growth, 3 quarters
55.4%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26